Efficacy and safety alone will no longer drive success in the life sciences industry. Clinical differentiation and demonstrated outcomes are the new imperatives. Product development lead times require a mid- to long-term perspective to characterize the competitive market landscape.
Kantar Health’s clinical and scientific assessment experts provide data and insights to successfully move your product through the clinical trial process and into the market. Our team has deep clinical and commercial expertise to support your most important business decisions.
- Pipeline prioritization and portfolio planning
- Assessment of merits of new compounds in development
- Standard-of-care analysis and emerging treatment trends
- Scientific meeting coverage
- Identifying, validating and advising on in-/out-licensing opportunities
- Providing input on clinical trial design to maximize market access